Marco Filetti

11PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedArtificial life and complex adaptive systemsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2025
The financial toll of cancer: uncovering the links between financial toxicity and symptom burden.

Marco Filetti, Pasquale Lombardi, Gabriella Gentile

|Apr 30, 2024
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors.

Raffaele Giusti, Giampiero Porzio, Marco Maltoni

|Jan 12, 2024
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis.

Marco Filetti, Pasquale Lombardi, Rosa Falcone

|Sep 15, 2023
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers.

Rosa Falcone, Marco Filetti, Pasquale Lombardi

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

Pageof 2

Frequent Collaborators

5 joint publications

Raffaele Giusti

5 joint publications

Pasquale Lombardi

5 joint publications

Gennaro Daniele

4 joint publications

Alessio Cortellini